[Therapeutic problems in the application of antiparkinsonian drugs in psychiatry].
This paper describes therapeutic problems concerning antiparkinsonian drugs in psychiatry. Particular attention was paid to problems like: 1. Possibility of making a therapeutic mistake of too prolonged and therefore harmful pharmacotherapy with antiparkinsonian drugs in the treatment of most common psychoses. 2. The importance of a careful selection of an optimal antiparkinsonian drug, especially in psyhogeriatric cases (for example Amantadinum). 3. The description of other indications for antiparkinsonian drugs: affective diseases or alcoholic withdrawal syndroms.
Piasecki
T
T
Z II Kliniki Chorób Psychicznych AM w Gdańsku.
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000150:complications / Q000188:drug therapy; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy*
D000978:Antiparkinson Agents; D004298:Dopamine
Problemy terapeutyczne zwiazane ze stosowaniem leków przeciwparkinsonowskich w psychiatrii.